Intrinsically Disordered Proteins in Human Diseases: Introducing The D2 Concept

Document Type

Article

Publication Date

2008

Keywords

Conformational Disease, Protein Misfolding, Intrinsic Disorder

Digital Object Identifier (DOI)

https://doi.org/10.1146/annurev.biophys.37.032807.125924

Abstract

Intrinsically disordered proteins (IDPs) lack stable tertiary and/or secondary structures under physiological conditions in vitro. They are highly abundant in nature and their functional repertoire complements the functions of ordered proteins. IDPs are involved in regulation, signaling, and control, where binding to multiple partners and high-specificity/low-affinity interactions play a crucial role. Functions of IDPs are tuned via alternative splicing and posttranslational modifications. Intrinsic disorder is a unique structural feature that enables IDPs to participate in both one-to-many and many-to-one signaling. Numerous IDPs are associated with human diseases, including cancer, cardiovascular disease, amyloidoses, neurodegenerative diseases, and diabetes. Overall, intriguing interconnections among intrinsic disorder, cell signaling, and human diseases suggest that protein conformational diseases may result not only from protein misfolding, but also from misidentification, missignaling, and unnatural or nonnative folding. IDPs, such as α-synuclein, tau protein, p53, and BRCA1, are attractive targets for drugs modulating protein-protein interactions. From these and other examples, novel strategies for drug discovery based on IDPs have been developed. To summarize work in this area, we are introducing the D2 (disorder in disorders) concept.

Was this content written or created while at USF?

Yes

Citation / Publisher Attribution

Annual Review of Biophysics, v. 37, p. 215-246

Link to Full Text

Share

COinS